Add Company
Join Now

MacuLogix Revenue and Competitors

License our Company Data API

Middletown, PA USA

Location

$64.3M

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • MacuLogix's estimated annual revenue is currently $2.6M per year.(i)
  • MacuLogix received $38.7M in venture funding in March 2019.
  • MacuLogix's estimated revenue per employee is $125,500
  • MacuLogix's total funding is $64.3M.

Employee Data

  • MacuLogix has 21 Employees.(i)
  • MacuLogix grew their employee count by -78% last year.

MacuLogix's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
Director Product InnovationReveal Email/Phone
4
Sr. Director OperationsReveal Email/Phone
5
Manager, Practice Management in Customer SuccessReveal Email/Phone
6
Sr. Manager, Professional RelationsReveal Email/Phone
7
Regional Sales ExecutiveReveal Email/Phone
8
SalesReveal Email/Phone
9
Sales Reveal Email/Phone
10
Sales Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$92.4M36826%N/AN/A
#2
$7M280%N/AN/A
#3
$46.2M18413%N/AN/A
#4
$2.6M21-78%$64.3MN/A
#5
$10.8M4316%N/AN/A
#6
$46.4M148-17%N/AN/A
#7
$26.1M10418%N/AN/A
#8
$26.9M1078%N/AN/A
#9
$40.7M1629%N/AN/A
#10
$38.9M15511%N/AN/A
Add Company

What Is MacuLogix?

MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professional to detect, monitor and start treating AMD three years before it can be seen in order to prevent vision loss. MacuLogix provides in-practice training and best practices to support the effective and efficient implementation and use of the AdaptDx

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$64.3M

Total Funding

21

Number of Employees

$2.6M

Revenue (est)

-78%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MacuLogix News

2019-08-31 - Diagnose AMD earlier with dark adaptation testing

The AdaptDx (MacuLogix) is a functional testing device that has been shown in clinical trials to identify patients with the earliest stages of AMD even when they ...

2019-03-11 - MacuLogix adds $38.7 million in Series D financing

MacuLogix has completed $38.7 million in Series D financing led by Vivo ... of funding brings MacuLogix's venture funding total to $51 million.

2019-03-07 - Pennsylvania-Based Eye Care Company MacuLogix Raises $38.7 Million

MacuLogix, a Harrisburg, Pennsylvania-based company that equips eye care professionals with the instruments, tools, and education they need to effectively diagnose and treat patients with age-related macular degeneration (AMD), has raised $38.7 million in Series D funding. This round of funding ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3M215%N/A
#2
$4.2M22-8%N/A
#3
$4.9M220%N/A
#4
$3.8M225%N/A
#5
$1.7M2433%N/A

MacuLogix Funding

DateAmountRoundLead InvestorsReference
2013-03-12$3.6MAMultipleArticle
2015-08-04$5.0MUndisclosedArticle
2018-07-20$10.0MUndisclosedHorizon Technology Finance CorporationArticle
2019-03-05$38.7MDVivo CapitalArticle